U A Shukla - JoVE Visualize

Showing results (21-30 of 31) with videos related to

Pageof 4

Sort By:

European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1992

Pharmacokinetics of nefazodone in the dog following single oral administrationU A Shukla, P H Marathe, J A Labudde, et al.

Pharmaceutical Research|November 1, 1995

Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humansP H Marathe, D E Salazar, D S Greene, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1990

Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetrationR H Barbhaiya, U A Shukla, C R Gleason, et al.

Clinical Pharmacology and Therapeutics|October 1, 1995

Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosisR H Barbhaiya, U A Shukla, C S Natarajan, et al.

European Journal of Clinical Pharmacology|January 1, 1994

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple dosesR H Barbhaiya, U A Shukla, M Pfeffer, et al.

Journal of Clinical Psychopharmacology|October 1, 1995

Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessmentP D Kroboth, M M Folan, R M Lush, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1990

Phase I study of multiple-dose cefprozil and comparison with cefaclorR H Barbhaiya, U A Shukla, C R Gleason, et al.

Journal of Clinical Pharmacology|October 1, 1995

Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I studyR H Barbhaiya, P H Marathe, D S Greene, et al.

Biopharmaceutics & Drug Disposition|April 1, 1984

Comparative bioavailability study of two tablet formulations of cimetidineR R Berardi, I A Cohen, M L Hyneck, et al.

Journal of Clinical Pharmacology|March 1, 1992

Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complexS M Pai, U A Shukla, T H Grasela, et al.

Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:

Pageof 4

European Journal of Drug Metabolism and Pharmacokinetics|October 1, 1992

Pharmacokinetics of nefazodone in the dog following single oral administrationU A Shukla, P H Marathe, J A Labudde, et al.

Pharmaceutical Research|November 1, 1995

Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humansP H Marathe, D E Salazar, D S Greene, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1990

Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetrationR H Barbhaiya, U A Shukla, C R Gleason, et al.

Clinical Pharmacology and Therapeutics|October 1, 1995

Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosisR H Barbhaiya, U A Shukla, C S Natarajan, et al.

European Journal of Clinical Pharmacology|January 1, 1994

Disposition kinetics of buspirone in patients with renal or hepatic impairment after administration of single and multiple dosesR H Barbhaiya, U A Shukla, M Pfeffer, et al.

Journal of Clinical Psychopharmacology|October 1, 1995

Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessmentP D Kroboth, M M Folan, R M Lush, et al.

Antimicrobial Agents and Chemotherapy|June 1, 1990

Phase I study of multiple-dose cefprozil and comparison with cefaclorR H Barbhaiya, U A Shukla, C R Gleason, et al.

Journal of Clinical Pharmacology|October 1, 1995

Safety, tolerance, and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I studyR H Barbhaiya, P H Marathe, D S Greene, et al.

Biopharmaceutics & Drug Disposition|April 1, 1984

Comparative bioavailability study of two tablet formulations of cimetidineR R Berardi, I A Cohen, M L Hyneck, et al.

Journal of Clinical Pharmacology|March 1, 1992

Population pharmacokinetic analysis of didanosine (2',3'-dideoxyinosine) plasma concentrations obtained in phase I clinical trials in patients with AIDS or AIDS-related complexS M Pai, U A Shukla, T H Grasela, et al.

Pageof 4